Forbes -
19 Dec 2014 21:22
While Walgreen's top line continues to grow, it faces ongoing pressure on gross margins. The company believes that the margin pressure will persist in the short-term. A cautious consumer, ongoing reimbursement pressure, generic drug inflation and significant step-downs from Med D reimbursement rates, are some of the factors that will act as headwinds in fiscal 2015. Nevertheless, Walgreen believes that it is well-positioned to capitalize on the industry tailwinds, which include an aging populati...
Share this Article
Comment on this Article
Please to comment